GPT and Hepatic fibrosis: Because the concentration of pyridoxin-5’-phosphate, a cofactor required in the full catalytic activity of AST and ALT, is significantly reduced in hemodialysis patients, the APRI cut-off values to stage hepatic fibrosis are lower in hemodialysis patients than in nonuremic patients [42].